Rituximab Maintenance Significantly Improves Progression-Free Survival In Patients With Follicular Lymphoma

Links shared publicly online about this topic.

  • 639
    total visits

Rituximab Maintenance Significantly Improves Progression-Free Survival In Patients With Follicular Lymphoma

medicalnewstoday.com

Patients with follicular lymphoma, a slow-growing common type of non-Hodgkin's lymphoma, who are given 2 years of rituximab-maintenance therapy after immunochemotherapy, have significantly better

View full resource at medicalnewstoday.com

Tags: Cancer, Lymphoma, Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma Medication, Rheumatoid Arthritis Medication, Rituxan, MabThera

  • Share

Most Recently Shared on December 21, 2010 at 3:05 pm By:

mnt_cancer MNT Cancer News

Rituximab Maintenance Significantly Improves Progression-Free Survival In Patients With Follicular Lymphoma http://mnt.to/3PkD #cancer

1 year ago...

Also Shared By:

MNT Leukemia MNT Leukemia

MNT Blood MNT Blood

Rituximab Extends Progression-Free Survival in Follicular Lymphoma - QualityPoint Technologies

qualitypointtech.net — “Patients with follicular lymphoma receiving rituximab maintenance therapy had significantly better progression-free survival but not overall survival. Medscape Medical NewsView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on December 29, 2010 at 3:45 pm By:

MedicalFeed MedicalFeed Health News Feed

Rituximab Extends Progression-Free Survival in Follicular Lymphoma: Patients with follicular lymphoma receiving ri... http://bit.ly/ezQlap

1 year ago...

Medical News: PFS Extended With Rituximab - in Oncology/Hematology, Lymphoma from MedPage Today

medpagetoday.com — “Maintenance therapy with rituximab (Rituxan) significantly improved progression-free survival in patients with follicular lymphoma following successful induction therapy, researchers said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 21, 2010 at 6:54 pm By:

PFS Extended With Rituximab (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- Maintenance therapy with rituximab (Rituxan) significantly improved progression-free survival in patients with follicular lymphoma following successful induction therapy, researchers said.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on December 21, 2010 at 6:45 pm By:

MedicalFeed MedicalFeed Health News Feed

PFS Extended With Rituximab (CME/CE): (MedPage Today) -- Maintenance therapy with rituximab (Rituxan) significantl... http://bit.ly/gq0r9r

1 year ago...

Advertisement